![]() “We’ve designed the new organization to fully tap into our combined capabilities, particularly in integrated supply chain operations, information technology and e-commerce.” We are excited to begin leveraging the proven operational excellence of our organizations to provide a growing customer base with more efficient and innovative solutions,” said Udit Batra, President and CEO of the life science business of Merck. “With the acquisition complete, we can now start tackling the challenge of solving the toughest problems in life science by collaborating with the global scientific community and helping to increase access to healthcare. The future organization will tap into the industry-leading talent of both legacy organizations, with a focus on promoting customer centricity, continuous innovation and strengthened capabilities. and Canada, where the business will be named MilliporeSigma. To ensure a smooth integration, Merck has made significant progress on integration planning for the new business, which will be named Merck all across the world, except for the U.S. “The acquisition of Millipore in 2010 was the first major step in that journey and with the completion of the Sigma-Aldrich acquisition, we will take a quantum leap toward securing our competitive position in that space.” “This is a significant milestone in Merck’s long-term strategy to invest in life science,” said Bernd Reckmann, Member of the Executive Board in charge of Merck’s Life Science and Performance Materials business sectors. The company will cover every step of the biotech production chain, creating a complete end-to-end workflow with enhanced customer service, a simplified customer interface and a leading distribution platform. With the acquisition of Sigma-Aldrich, Merck will be able to serve life science customers around the world with a highly attractive set of established brands such as SAFC and BioReliance, in addition to Millipore and Milli-Q, as well as an efficient supply chain that can support the delivery of more than 300,000 products. Merck has made acquisitions and divestments totalling € 38 billion in the past decade, turning the former pharma and chemicals company into a science and technology company with three businesses in healthcare, life science and performance materials that serve as platforms to compete in their markets and drive innovations in these industries. “We’re now a leading player in the $ 130 billion global life science industry and together with our two other growth platforms Healthcare and Performance Materials, Merck is set to tackle global challenges that will fundamentally change the world in which we live.” “The acquisition of Sigma-Aldrich marks the culmination of almost a decade of transformation, further affirming that Merck is a leading science and technology company,” said Karl-Ludwig Kley, CEO and Chairman of Merck. As announced on publication of the results for the third quarter of 2015 on November 12, Merck expects sales to amount to between € 12.6 billion and € 12.8 billion in 2015. Combined pro forma full-year life science sales amounted to € 4.6 billion in 2014. Following the acquisition, Merck will have around 50,000 employees in 67 countries, working at 72 manufacturing sites worldwide. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Aldrich transaction. Organizational structure and senior management team in placeĭarmstadt, Germany, NovemMerck, a leading science and technology company, today announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry to help solve the toughest problems in life science.Customers benefit from a more than 300,000-product offering with highly-respected brands distributed through leading life science e-commerce and distribution platform.New entity to enhance product range, capabilities and geographic reach. ![]() $ 17 billion acquisition establishes leading player in life science industry.Our robust portfolio, developed by analytical chemists for analytical chemists, covers a broad range of analytical solutions and every product undergoes meticulous quality control to maintain the integrity of your testing protocols.Īnd with Supelco® scientists dedicated to your lab, the expertise you need is always on hand.Merck Completes Sigma-Aldrich Acquisition That’s why MilliporeSigma offers the Supelco® portfolio of analytical products, putting quality and compliance at the forefront of our work to ensure your results are reproducible and your systems fully certified. We know only the most precise analytical products will do.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |